scispace - formally typeset
M

Michael L. Terrin

Researcher at University of Maryland, Baltimore

Publications -  139
Citations -  17598

Michael L. Terrin is an academic researcher from University of Maryland, Baltimore. The author has contributed to research in topics: Randomized controlled trial & Myocardial infarction. The author has an hindex of 49, co-authored 132 publications receiving 16139 citations. Previous affiliations of Michael L. Terrin include Mount Sinai St. Luke's and Mount Sinai Roosevelt & University of Cincinnati.

Papers
More filters
Journal ArticleDOI

Cluster-randomized trial of a mobile phone personalized behavioral intervention for blood glucose control. Diabetes Care 2011;34:1934–1942

TL;DR: In the article listed above, the values for the 9-month glycated hemoglobins are incorrect due to a programming error.
Journal ArticleDOI

Effects of acute hormone therapy on recurrent ischemia in postmenopausal women with unstable angina

TL;DR: Acute hormone therapy does not reduce ischemia in PMP women with UA when added to standard anti-ischemic therapy, and the percentage of patients with ischemic events and the mean duration of ischemIA did not differ between hormone- and placebo-treated patients.
Journal ArticleDOI

Effect of Doxycycline on Aneurysm Growth Among Patients With Small Infrarenal Abdominal Aortic Aneurysms: A Randomized Clinical Trial.

TL;DR: Among patients with small infrarenal abdominal aortic aneurysms, doxycycline compared with placebo did not significantly reduce aneurYSm growth at 2 years, and these findings do not support the use of doxy cycline for reducing the growth of small abdominal aorts.
Journal ArticleDOI

Mobile diabetes intervention study: testing a personalized treatment/behavioral communication intervention for blood glucose control.

TL;DR: Traditional methods of disease management have not achieved adequate control for BG and other conditions important to persons with diabetes, and tools to improve communication between patients and PCPs may improve patient outcomes and be satisfactory to patients and physicians.
Journal ArticleDOI

The late open artery hypothesis--a decade later.

TL;DR: The hypothesis that late reperfusion by percutaneous coronary intervention days to weeks after myocardial infarction results in improved long-term clinical outcomes in asymptomatic patients with occluded infarct-related artery is currently being tested in the randomized, multicenter Occluded Artery Trial.